Sontochin as a guide to the development of drugs against chloroquine-resistant malaria

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 3475-3480

  Pou, Sovitj ^a   Winter, Rolf W ^a,c   Nilsen, Aaron ^a   Kelly, Jane Xu ^a,c   Li, Yuexin ^a   Doggett, J Stone ^a,d   Riscoe, Erin W ^b   Wegmann, Keith W ^a   Hinrichs, David J ^a,b   Riscoe, Michael K ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND STATE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYL GROUP; CHLOROQUINE; HALOFANTRINE; MEPACRINE; PHARMACHIN 112; PHARMACHIN 127; PHARMACHIN 128; PHARMACHIN 132; PHARMACHIN 137; PHARMACHIN 161; PHARMACHIN 203; POTASSIUM CHANNEL HERG; QUININE; SONTOQUINE; UNCLASSIFIED DRUG; VERAPAMIL; WARFARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALARIA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; QT INTERVAL;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; INHIBITORY CONCENTRATION 50; MALARIA; MICE; MOLECULAR STRUCTURE; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII;

EID: 84862519697     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00100-12     Document Type: Article

References (33)

1. Ager AJ. 1984. Rodent malaria models, vol 68/I. Springer-Verlag, Berlin, Germany.
2. Andersag H. 1948. Antimalariamittel aus der Gruppe halogensubstituierter Chinolinverbindungen. Chem. Ber. 81:499-507.
3. Andersag H, Breitner S, Jung H. March 1941. Quinoline compound and process of making the same. US Patent 2,233,970.
4. Berliner RW, et al. 1948. Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. J. Clin. Invest. 27:98-107.
5. Blanchard K. 1947. Antimalarial drugs. Annu. Rev. Biochem. 16:587-604.
6. Coatney GR. 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am. J. Trop. Med. Hyg. 12:121-128.
7. De D, Krogstad FM, Cogswell FB, Krogstad DJ. 1996. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 55:579-583.
8. Drake N, et al. 1946. Synthetic antimalarials. The preparation of certain 4-aminoquinolines. J. Am. Chem. Soc. 68:1208-1213.
9. Fairley N. 1949. Malaria. With special reference to certain experimental, clinical, and chemotherapeutic investigations. BMJ 1949:891-897.
10. Fairley NH. 1946. Atebrin susceptibility of the Aitaipe-Wewak strains of P. falciparum and P. vivax; a field and experimental investigation by L. H. Q. Medical Research Unit, Cairns. Trans. R. Soc. Trop. Med. Hyg. 40:229-273.
11. Fernando SD, Rodrigo C, Rajapakse S. 2010. The 'hidden' burden of malaria: cognitive impairment following infection. Malar. J. 9:366.
12. Fidock AD, et al. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
13. Geary TG, Divo AA, Jensen JB. 1987. Activity of quinoline-containing antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 81:499-503.
14. Geary TG, Jensen JB. 1983. Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro. J. Parasitol. 69:97-105.
15. Martin RE, et al. 2009. Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 325:1680-1682.
16. Mzayek F, et al. 2007. Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers. PLoS Clin. Trials 2:e6. doi:10.1371/journal.pctr.0020006.
17. Oduola AM, Milhous WK, Salako LA, Walker O, Desjardins RE. 1987. Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet 330:1304-1305.
18. Olliaro P, Goldberg D. 1995. The Pasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol. Today 11:294-297.
19. O'Neill PM, et al. 2003. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. J. Med. Chem. 46:4933-4945.
20. O'Neill PM, et al. 2006. A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs. Curr. Top. Med. Chem. 6:479-507.
21. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. 2000. The structure of malaria pigment beta-haematin. Nature 404:307-310.
22. Petersen I, Eastman R, Lanzer M. 2011. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 585:1551-1562.
23. Pisciotta JM, et al. 2007. The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem. J. 402:197-204.
24. Ridley RG, et al. 1996. 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40:1846-1854.
25. Roepe PD. 2010. PfCRT-mediated drug transport in malarial parasites. Biochemistry 50:163-171.
26. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. 2004. Simple and inexpensive fluorescence-based technique for highthroughput antimalarial drug screening. Antimicrob. Agents Chemother. 48:1803-1806.
27. Stocks PA, et al. 2002. Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum. J. Med. Chem. 45:4975-4983.
28. Summers RL, Martin RE. 2010. Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy. Virulence 1:304-308.
29. Tarbell DS, et al. 1946. The synthesis of some 7-chloro-4-(3- alkylaminopropylamino) quinolines. J. Am. Chem. Soc. 68:1217-1219.
30. Traebert M, et al. 2004. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Eur. J. Pharmacol. 484:41-48.
31. Trager W, Jensen JB. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
32. Winter RW, et al. 2006. Evaluation and lead optimization of anti-malarial acridones. Exp. Parasitol. 114:47-56.
33. Wiselogle FY (ed). 1946. A survey of antimalarial drugs, 1941-1945. J. W. Edwards, Ann Arbor, MI.